Endometrial cancer recurred three years after surgery

Three years after surgical treatment of early endometrial cancer, the uterus is enlarged during follow-up examination, which is a recurrence of uterine cancer. If the patient is in good physical condition, local radiotherapy can be considered. The total recurrence rate of endometrial cancer is generally 10 to 20%, and most patients relapse within three years. If there is no recurrence within five years of treatment, the possibility of recurrence in the future is extremely small.

There are two types of recurrence of endometrial cancer: local recurrence, such as the reappearance of cancer in the vagina or pelvis after hysterectomy; and systemic recurrence, i.e., tumors found in any part of the body after treatment. Vaginal recurrence is the most common site, with an incidence of 20% to 30%, and the pelvic recurrence rate is about 3%.

Since endometrial cancer may recur within three years after treatment, it is necessary to conduct regular follow-up after treatment of uterine cancer. Most cases are reviewed every three to four months; in the next three years, every six months; and once a year thereafter.

Follow-up visits include medical history, gynecological examination, Pap smear, breast examination and CA-125 test. If the CA-125 value is very high when initially diagnosed, it needs to be tested every six months. If the value is continuously high during follow-up examination, timely treatment is required.

There are two types of recurrence of endometrial cancer: local recurrence, such as the reappearance of cancer in the vagina or pelvis after hysterectomy; and systemic recurrence, i.e., tumors found in any part of the body after treatment. Vaginal recurrence is the most common site, with an incidence of 20% to 30%, and the pelvic recurrence rate is about 3%.

Since endometrial cancer may recur within three years after treatment, it is necessary to conduct regular follow-up after treatment of uterine cancer. Most cases are reviewed every three to four months; in the next three years, every six months; and once a year thereafter.

Follow-up visits include medical history, gynecological examination, Pap smear, breast examination and CA-125 test. If the CA-125 value is very high when initially diagnosed, it needs to be tested every six months. If the value is continuously high during follow-up examination, timely treatment is required.